Grymonprez M - Search Results

1

Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants: an intervention study in community pharmacies.

Capiau A, Mehuys E, Grymonprez M, Van Tongelen I, Christiaens T, Tommelein E, Philippe G, Lahousse L, De Backer T, Boussery K. Capiau A, et al. Among authors: grymonprez m. Thromb Res. 2024 May 7;238:223-231. doi: 10.1016/j.thromres.2024.05.006. Online ahead of print. Thromb Res. 2024. PMID: 38733695

2

Potentially inappropriate prescribing in multimorbid and polymedicated older adults with AF: A Systematic Review and Meta-Analysis.

Amrouch C, Vauterin D, Amrouch S, Grymonprez M, Dai L, Damiano C, Calderón-Larrañaga A, Lahousse L, De Bacquer D, Lip GYH, Vetrano DL, De Smedt D, Petrovic M; AFFIRMO consortium. Amrouch C, et al. Among authors: grymonprez m. Drugs Aging. 2024 Jan;41(1):13-30. doi: 10.1007/s40266-023-01078-6. Epub 2023 Nov 17. Drugs Aging. 2024. PMID: 37976015 Free PMC article.

3

Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study.

Grymonprez M, Capiau A, Steurbaut S, Boussery K, Mehuys E, Somers A, Petrovic M, De Backer TL, Lahousse L. Grymonprez M, et al. Cardiovasc Drugs Ther. 2023 Nov 6. doi: 10.1007/s10557-023-07521-5. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 37930588

4

Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study.

Grymonprez M, Carnoy L, Capiau A, Boussery K, Mehuys E, De Backer TL, Steurbaut S, Lahousse L. Grymonprez M, et al. Eur Heart J Cardiovasc Pharmacother. 2023 Dec 14;9(8):722-730. doi: 10.1093/ehjcvp/pvad070. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 37791408

5

Minimal Adherence Threshold to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation to Reduce the Risk of Thromboembolism and Death: A Nationwide Cohort Study.

Grymonprez M, Steurbaut S, Capiau A, Vauterin D, Van Vaerenbergh F, Mehuys E, Boussery K, De Backer TL, Lahousse L. Grymonprez M, et al. Cardiovasc Drugs Ther. 2023 Sep 14. doi: 10.1007/s10557-023-07507-3. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 37707648

6

Venous thromboembolism in patients with psoriasis: a retrospective single-centre chart review of an overlooked comorbidity.

Hillary T, Grymonprez M, Vanhooren E, Güvenç C, Garmyn M, Vermeire S. Hillary T, et al. Among authors: grymonprez m. Clin Exp Dermatol. 2023 Dec 19;49(1):75-76. doi: 10.1093/ced/llad292. Clin Exp Dermatol. 2023. PMID: 37655942 No abstract available.

7

Barriers and facilitators for adherence to direct oral anticoagulants in patients with atrial fibrillation: A qualitative approach.

Capiau A, Grymonprez M, Scheire S, Faute Y, Lahousse L, Mehuys E, De Backer T, Boussery K. Capiau A, et al. Among authors: grymonprez m. Thromb Res. 2023 Sep;229:164-169. doi: 10.1016/j.thromres.2023.06.012. Epub 2023 Jun 15. Thromb Res. 2023. PMID: 37515981 No abstract available.

8

The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.

Grymonprez M, Petrovic M, De Backer TL, Steurbaut S, Lahousse L. Grymonprez M, et al. Thromb Haemost. 2024 Feb;124(2):135-148. doi: 10.1055/s-0043-1769735. Epub 2023 Jun 27. Thromb Haemost. 2024. PMID: 37369234 Free PMC article.

9

Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants: A nationwide cohort study.

Grymonprez M, Petrovic M, De Backer TL, Steurbaut S, Lahousse L. Grymonprez M, et al. Int J Cardiol Heart Vasc. 2023 May 18;47:101223. doi: 10.1016/j.ijcha.2023.101223. eCollection 2023 Aug. Int J Cardiol Heart Vasc. 2023. PMID: 37252193 Free PMC article.

10

Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study.

Grymonprez M, Petrovic M, De Backer TL, Steurbaut S, Lahousse L. Grymonprez M, et al. Eur Heart J Qual Care Clin Outcomes. 2024 Jan 12;10(1):55-65. doi: 10.1093/ehjqcco/qcad019. Eur Heart J Qual Care Clin Outcomes. 2024. PMID: 36941126 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page